Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Polycystic Ovary Syndrome 2Neoplasms 2Urinary Bladder Neoplasms 1Stage I Prostate Adenocarcinoma 1Prostatic Neoplasms 1Osteoporosis 1Infertility 1Endometrial Neoplasms 1Diarrhea 1Brain Neoplasms 1Anovulation 1

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Calcium 6Letrozole 4Cholecalciferol 4Calcium Carbonate 4Alendronate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Nutrition Assessment 2Goserelin 2Estradiol 2Denosumab 2Calcium Gluconate 2Aromatase Inhibitors 2Absorptiometry, Photon 2xian ling gu bao 1romosozumab 1X-Rays 1Technetium 1Raloxifene Hydrochloride 1Progesterone 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Lysine Acetyltransferase 5 1Ibandronic Acid 1Hormone Replacement Therapy 1Geritol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Osteoporosis × Raloxifene Hydrochloride × Clear all
NCT00031811 2012-05-28

Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer

OHSU Knight Cancer Institute

Phase NA Completed
80 enrolled
Breast

Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡